Novel human neuropeptide Y Y5 receptor antagonists for the treatment of obesity synthesis and biological evaluation of pyridine hydrazide derivatives
2011
A series of new pyridine hydrazide derivatives with high and selective antagonist activity at the human neuropeptide Y Y 5 receptor were developed. Introduction of electron-withdrawing groups into the arylsulfonamide rest, together with the 3-pyridyl analogue in the hydrazide moiety, led to a significant improvement of potency and solubility, affording trans-N-{4-[N'-(pyridine-3-carbonyl)hydrazino-carbonyl]cyclohexylmethyl}-2,4-dichloro-benzenesulfonamide (14), which binds to the hY 5 receptor with an IC 50 value of 7.44 nmol/L.
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
2
Citations
NaN
KQI